Healthcare ❯ Regulatory Affairs

FDA Approvals

Drug Applications Drug Indications Drug Safety Drug Development Medical Device Clearance Drug Approval Process Veterinary Medicine Drug Efficacy New Drug Formulations Medical Devices Drug Launches Drug Approvals Brinsupri Metabolic Disorders Drug Submissions

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

The once-daily peptide offers biologic-like efficacy without injections.

Repurposed Epilepsy Drug Cuts Sleep Apnea Events by Up to 47% in Phase II Trial

Ironwood Sees LINZESS Above $1.1 Billion in 2026 as FDA-Aligned STARS II Nears Launch

Dexcom Posts Q4 Beat, Launches 15‑Day G7, Reaffirms 2026 Outlook

BioMarin to Acquire Amicus for $4.8 Billion in Cash

FDA Adds Brain Tumor Warning to Two Depo‑Provera Injections

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

Regeneron Tops Q3 Forecasts on Dupixent Strength as Eylea HD Faces FDA Delay

Amgen Reports Repatha Cuts First-Event Risk in Primary-Prevention Trial

Merck Wins FDA Approval for Subcutaneous Keytruda as EU Panel Backs Infant RSV Preventive

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy